Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Associations of Pulse and Blood Pressure with Hippocampal Volume by APOE and Cognitive Phenotype: The Alzheimer's Disease Neuroimaging Initiative (ADNI).

Ngwa JS, Fungwe TV, Ntekim O, Allard JS, Johnson SM, Castor C, Graham L, Nadarajah S, Gillum RF, Obisesan TO; Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2018;45(1-2):66-78. doi: 10.1159/000486955. Epub 2018 Apr 25.

2.

MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Schuff N, Woerner N, Boreta L, Kornfield T, Shaw LM, Trojanowski JQ, Thompson PM, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Brain. 2009 Apr;132(Pt 4):1067-77. doi: 10.1093/brain/awp007. Epub 2009 Feb 27.

3.

The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.

Löwe LC, Gaser C, Franke K; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2016 Jul 13;11(7):e0157514. doi: 10.1371/journal.pone.0157514. eCollection 2016.

4.

A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease.

Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Vellas B, Soininen H, Kloszewska I, Tsolaki M, Mecocci P, Spenger C, Villemagne VL, Masters CL, Muehlboeck JS, Bäckman L, Fratiglioni L, Kalpouzos G, Wahlund LO, Schumann G, Lovestone S, Williams SC, Westman E, Simmons A; Alzheimer–s Disease Neuroimaging Initiative; AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group; IMAGEN consortium.

J Alzheimers Dis. 2017;56(3):1159-1174. doi: 10.3233/JAD-161097.

5.

Dissecting the gene dose-effects of the APOE ε4 and ε2 alleles on hippocampal volumes in aging and Alzheimer's disease.

Hostage CA, Roy Choudhury K, Doraiswamy PM, Petrella JR; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2013;8(2):e54483. doi: 10.1371/journal.pone.0054483. Epub 2013 Feb 6.

6.

Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.

Teng E, Chow N, Hwang KS, Thompson PM, Gylys KH, Cole GM, Jack CR Jr, Shaw LM, Trojanowski JQ, Soares HD, Weiner MW, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative.

Dement Geriatr Cogn Disord. 2015;39(3-4):154-66. doi: 10.1159/000368982. Epub 2014 Dec 24.

7.

Relationship of medial temporal lobe atrophy, APOE genotype, and cognitive reserve in preclinical Alzheimer's disease.

Soldan A, Pettigrew C, Lu Y, Wang MC, Selnes O, Albert M, Brown T, Ratnanather JT, Younes L, Miller MI; BIOCARD Research Team.

Hum Brain Mapp. 2015 Jul;36(7):2826-41. doi: 10.1002/hbm.22810. Epub 2015 Apr 16.

8.

Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.

Gomar JJ, Conejero-Goldberg C, Huey ED, Davies P, Goldberg TE; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2016 Mar;39:165-73. doi: 10.1016/j.neurobiolaging.2015.12.004. Epub 2015 Dec 19.

PMID:
26923413
9.

Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.

Seo EH, Kim SH, Park SH, Kang SH, Choo IH; Alzheimer's Disease Neuroimaging Initiative.

J Korean Med Sci. 2016 Feb;31(2):286-95. doi: 10.3346/jkms.2016.31.2.286. Epub 2016 Jan 13.

10.

Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts.

Khan W, Westman E, Jones N, Wahlund LO, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Muehlboeck JS, Simmons A; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative.

Brain Topogr. 2015 Sep;28(5):746-759. doi: 10.1007/s10548-014-0415-1. Epub 2014 Nov 5.

11.

Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.

Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.

J Alzheimers Dis. 2015;45(3):781-95. doi: 10.3233/JAD-142556.

PMID:
25624419
12.

Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.

Shi J, Leporé N, Gutman BA, Thompson PM, Baxter LC, Caselli RJ, Wang Y; Alzheimer's Disease Neuroimaging Initiative.

Hum Brain Mapp. 2014 Aug;35(8):3903-18. doi: 10.1002/hbm.22447. Epub 2014 Jan 22.

13.

Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.

Da X, Toledo JB, Zee J, Wolk DA, Xie SX, Ou Y, Shacklett A, Parmpi P, Shaw L, Trojanowski JQ, Davatzikos C; Alzheimer's Neuroimaging Initiative.

Neuroimage Clin. 2013 Nov 28;4:164-73. doi: 10.1016/j.nicl.2013.11.010. eCollection 2014.

14.

Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan.

Wang PN, Lirng JF, Lin KN, Chang FC, Liu HC.

Neurobiol Aging. 2006 Dec;27(12):1797-806.

PMID:
16321457
15.

Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.

Lim YY, Williamson R, Laws SM, Villemagne VL, Bourgeat P, Fowler C, Rainey-Smith S, Salvado O, Martins RN, Rowe CC, Masters CL, Maruff P; AIBL Research Group.

J Alzheimers Dis. 2017;58(4):1293-1302. doi: 10.3233/JAD-170072.

PMID:
28550258
16.

The Relationship of Brain Amyloid Load and APOE Status to Regional Cortical Thinning and Cognition in the ADNI Cohort.

Li C, Loewenstein DA, Duara R, Cabrerizo M, Barker W, Adjouadi M; Alzheimer’s Disease Neuroimaging Initiative.

J Alzheimers Dis. 2017;59(4):1269-1282. doi: 10.3233/JAD-170286.

17.

APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.

Manning EN, Barnes J, Cash DM, Bartlett JW, Leung KK, Ourselin S, Fox NC; Alzheimer's Disease NeuroImaging Initiative.

PLoS One. 2014 May 30;9(5):e97608. doi: 10.1371/journal.pone.0097608. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e104482.

18.

Correlations between cerebellar and brain volumes, cognitive impairments, ApoE levels, and APOE genotypes in patients with AD and MCI.

Łojkowska W, Witkowski G, Bednarska-Makaruk M, Wehr H, Sienkiewicz-Jarosz H, Graban A, Bochyńska A, Wiśniewska A, Gugała M, Sławińska K, Sawicka B, Poniatowska R, Ryglewicz D.

Curr Alzheimer Res. 2013 Nov;10(9):964-72.

PMID:
24117117
20.

Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Waring SC, Tangalos EG, Smith GE, Ivnik RJ, Thibodeau SN, Kokmen E.

Ann Neurol. 1998 Mar;43(3):303-10. Review.

Supplemental Content

Support Center